Atherosclerosis is not a risk factor for anti-platelet factor 4/heparin antibody formation after cardiopulmonary bypass surgery.
Adam Cuker, MD, MS, Hospital of the University of Pennsylvania, 3 Dulles, 3400 Spruce Street, Philadelphia, PA 19104, USA, Tel.: +1 215 615 6555, Fax: +1 215 615 6599, E-mail: adam.cuker@uphs.upenn.edu.
Adam
A
Cuker
Lubica
L
Rauova
Douglas
D
Bolgiano
William H
WH
Matthai
Mortimer
M
Poncz
Barbara A
BA
Konkle
D000368:Aged; D050197:Atherosclerosis / Q000150:complications / Q000276:immunology* / Q000601:surgery*; D001323:Autoantibodies / Q000096:biosynthesis; D002315:Cardiopulmonary Bypass / Q000009:adverse effects*; D015331:Cohort Studies; D005260:Female; D006493:Heparin / Q000009:adverse effects* / Q000276:immunology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010978:Platelet Factor 4 / Q000276:immunology*; D011446:Prospective Studies; D012307:Risk Factors; D013921:Thrombocytopenia / Q000209:etiology / Q000276:immunology
D001323:Autoantibodies; D010978:Platelet Factor 4; D006493:Heparin